EVO756

· Evommune, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for EVO756, covering 2025-06-18 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b Study of EVO756 in Adults With Atopic Dermatitis [Phase 2]